# Electroacupuncture for Preventing Adverse Events of Cancer Immunotherapy

> **NCT06891521** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Qinghai Red Cross Hospital** · enrollment: 123 (estimated)

## Conditions studied

- Cancer
- Adverse Events

## Interventions

- **PROCEDURE:** Electroacupuncture

## Key facts

- **NCT ID:** NCT06891521
- **Lead sponsor:** Qinghai Red Cross Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-20
- **Primary completion:** 2027-03-01
- **Final completion:** 2028-06-01
- **Target enrollment:** 123 (ESTIMATED)
- **Last updated:** 2025-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06891521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06891521, "Electroacupuncture for Preventing Adverse Events of Cancer Immunotherapy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06891521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*